NeuroPace Investor Relations Material
Latest events
Q2 2025
NeuroPace
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeuroPace Inc
Access all reports
NeuroPace Inc designs and manufactures neurostimulation systems for the treatment of neurological disorders such as epilepsy. The company’s responsive neurostimulation technology monitors brain activity and delivers targeted stimulation to prevent seizures. It serves the medical device and neurology markets. The company is headquartered in Mountain View, California, and its shares are listed on the NASDAQ.
Key slides for NeuroPace Inc
Investor Presentation
NeuroPace Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
NeuroPace Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NPCE
Country
🇺🇸 United States